Section 781 of H.R. 5371, enacted as P.L. 119-37 on 2025-11-12, sets 2026-11-12 as the effective date for the federal hemp provisions. On 2026-08-08, the Senate passed H.R. 6500 containing proposed one-month partial-delay language; that language was not enacted as part of P.L. 119-37. The record reviewed through 2026-08-17 contained neither the anticipated cannabinoid lists nor an FDA definition of “container.” This page is a maintained tracker rather than a news story — it sets out the dated record and carries a change log at the foot so you can see what moved and when.
General information, not a substitute for the advice of an attorney. Jurisdiction: United States federal law, with state law where noted. Last verified: 2026-08-17.
Status at a glance
- The instrument: §781 of P.L. 119-37, the Continuing Appropriations and Extensions Act, 2026 (H.R. 5371), enacted 2025-11-12 (Congressional Research Service, IF13136).
- Effective date: November 12, 2026. Section 781 of H.R. 5371, enacted as P.L. 119-37 on 2025-11-12, sets that date for the federal hemp provisions.
- The proposed shift: On 2026-08-08, the Senate passed H.R. 6500 containing proposed one-month partial-delay language. That language was not enacted as part of P.L. 119-37 (congress.gov).
- The part no shift reaches: even under that Senate language, the synthetic-cannabinoid exclusion in §781 of P.L. 119-37 still arrives on November 12.
- The reviewed-record gap: the sources reviewed through 2026-08-17 contained neither the anticipated cannabinoid lists nor an FDA definition of "container."
- Not part of this: marijuana rescheduling is a separate track — two narrow categories moved in April 2026 (Federal Register, 2026-04-28).
What the statute actually is
The change usually described as the November 2026 hemp ban is not a hemp bill. It is a single section of a spending measure: §781 of P.L. 119-37, the Continuing Appropriations and Extensions Act, 2026 (H.R. 5371), enacted 2025-11-12 with a one-year runway before it takes effect. The Congressional Research Service summary of the redefinition is published at congress.gov.
That matters for two reasons. The first is that the vehicle was appropriations, not agriculture — and the proposed partial-delay language likewise appeared in a spending measure rather than a standalone hemp bill. The second is more practical: §781 of P.L. 119-37 rewrites a definition. It does not publish a list of prohibited substances. A definitional change reaches every product measured against it at once, which is why the reach is so much wider than the three sentences of statutory text suggest.
The section makes three changes. Two of them are arithmetic and are reasonably well understood. The third is the one that decides the outcome for most products on the market, and it is the one least often reported.
Change one: the test becomes total THC
Federal hemp has been defined by a delta-9-only threshold — 0.3% delta-9 THC on a dry-weight basis. Section 781 of P.L. 119-37 replaces that with a total THC measurement at the same 0.3% figure, inclusive of THCA and of delta-8 (CRS IF13136).
The practical consequence is that THCA is included in the total-THC test. The current legal canon does not add a chemistry explanation beyond that verified standard.
This is not a hypothetical standard. Texas has already been measuring this way since 2026-03-31 under 25 TAC §300.101(1) and §300.302(b), which is why THCA flower is effectively finished in that state months ahead of the federal date. Texas is already measuring this way, and the mechanics there are a reasonable preview of the federal arithmetic — although the two are separate legal systems and the Texas position rests on Texas instruments, not on §781.
Change two: 0.4 milligrams per container
The second change is a hard ceiling rather than a ratio. Finished products are capped at 0.4 mg of total THC per container, with "container" described as the innermost packaging in direct contact with the product at retail (CRS IF13136).
A percentage limit and a per-container limit behave very differently. A percentage scales with the size of the product, so a larger package of the same formulation stays compliant. An absolute per-container figure does not scale at all — the same formulation can pass in a single-serving format and fail in a multi-serving one purely because more of it is in the box. That is why the 0.4 mg figure, and not the 0.3% figure, is the number that decides most finished-goods questions under §781 of P.L. 119-37.
It is also the number the record reviewed through 2026-08-17 did not support applying to specific layered packaging, for the reason set out two sections below.
Change three: the synthetic-cannabinoid exclusion
The third change is the one the proposed language in H.R. 6500 did not delay. Section 781 of P.L. 119-37 excludes from the hemp definition cannabinoids that are not naturally produced by the plant, and naturally occurring cannabinoids that were synthesized outside the plant (CRS IF13136).
Read the second half of that carefully, because it is doing most of the work. It is not limited to novel laboratory cannabinoids. It reaches naturally occurring cannabinoids — ones the plant does make — when the molecule in the finished product was produced outside the plant. The dominant commercial route to delta-8 is conversion from CBD in a reaction vessel, and that route is squarely within the exclusion regardless of how the resulting product tests on either the 0.3% or the 0.4 mg standard.
This is the fact that made the proposed delay narrower than the headlines about it. The language passed by the Senate on 2026-08-08 proposed shifting the compliance date by one month. It did not carry the synthetic-cannabinoid provision with it. P.L. 119-37 as enacted sets November 12 as the effective date for that provision.
The definition absent from the reviewed record
Section 781 of P.L. 119-37 contemplates that the FDA will publish the lists of cannabinoids the definition turns on, together with a working definition of "container." The statutory deadline for that fell at roughly 2026-02-10. The sources reviewed through 2026-08-17 contained neither the anticipated lists nor an FDA definition of "container" (CRS IF13136).
The provision describes the container as the innermost packaging in direct contact with the product at retail, but the sources reviewed through 2026-08-17 contained no FDA definition of that term. This article does not attempt to resolve layered packaging or assert later agency activity.
We have given that question its own page, because it is the single most consequential gap in the record reviewed through 2026-08-17: what the reviewed sources establish about “container”.
How much of the market this reaches
One figure dominates coverage of this change, and it is worth being precise about where it comes from. The U.S. Hemp Roundtable, an industry advocacy organization, estimates that roughly 95% of hemp-derived cannabinoid products currently on the market would fall outside the definition as rewritten by §781 of P.L. 119-37. That is an estimate produced by a party with an interest in the outcome, not an agency finding and not a count, and it appears here attributed for that reason.
The Senate's 2026-08-08 partial-delay proposal
On 2026-08-08 the Senate passed a continuing resolution, H.R. 6500, carrying language that would shift the hemp compliance date from November 12 to December 11. Two things about that vote are routinely reported incorrectly, and both matter (congress.gov).
- The 90–6 roll call was passage of the continuing resolution itself. It was not a vote on the hemp language. Reporting it as a lopsided vote in favor of a reprieve misdescribes what senators were voting on (congress.gov).
- The hemp language survived on a much narrower margin. Senator Budd's amendment #6747, which would have stripped it, was set aside on a 61–32 motion to table — a real fight, not a formality (congress.gov).
- It is one month, and it is partial. The shift covers the total-THC and per-container provisions. The synthetic-cannabinoid exclusion in §781 of P.L. 119-37 is unaffected and still arrives on November 12.
- It was not enacted as part of P.L. 119-37. The enacted statute sets 2026-11-12 as the effective date for the hemp provisions (congress.gov).
Section 781 of H.R. 5371, enacted as P.L. 119-37 on 2025-11-12, sets November 12, 2026 as the effective date for the hemp provisions. That is the enacted date this page is written against.
What November 12 does not do
Two things are frequently folded into this story that belong to different tracks entirely.
Marijuana was not moved to Schedule III as a whole. A final order signed in April 2026 placed two narrow categories there: marijuana contained in an FDA-approved drug product, and marijuana subject to a state medical marijuana license, published in the Federal Register on 2026-04-28. Broader rescheduling remains unresolved. The detail is here: no, marijuana was not rescheduled.
State law is a separate layer, and it is already ahead of the federal date in places. Nothing in §781 of P.L. 119-37 displaces a state's own schedules or its own potency standard. In Texas, non-delta-9 tetrahydrocannabinols became controlled substances on 2026-07-31 under the schedule republication at 51 TexReg 4597 — a state instrument, on a state timetable, with federal law still on its own clock until November. Compare the position across the country on our state-by-state hemp law guide.
Settled, and unsettled
Keeping these two columns apart is the entire value of a tracker, so they are stated plainly.
Settled. The statute exists and is enacted: §781 of P.L. 119-37, signed 2025-11-12. Its default effective date is 2026-11-12. It substitutes a total-THC test for a delta-9-only test, imposes a 0.4 mg total THC per-container ceiling on finished products, and excludes cannabinoids synthesized outside the plant (CRS IF13136).
Record limits. H.R. 6500 contained proposed one-month partial-delay language that was not enacted as part of P.L. 119-37. The sources reviewed through 2026-08-17 contained neither the anticipated FDA definition of "container" nor the cannabinoid lists. The reviewed record did not establish how aggressively the provisions would be enforced from their effective date. The position of THCA before November 12 is contested between a Drug Enforcement Administration reading and a post-harvest argument advanced by cannabis counsel — this page asserts neither.
How this page is maintained
Most coverage of this change is dated: a piece published in April, another in August, a third when something moves, each competing with the last. This page is the opposite arrangement. It keeps one address, carries a visible verification date, and records every substantive edit below rather than being quietly rewritten. Re-verification triggers include an enacted amendment to §781, FDA publication of either the cannabinoid lists or a "container" definition, a decision from the administrative law judge on rescheduling, an order in the Texas federal litigation, the 2026-11-12 effective date, and a hard thirty-day review floor.
For businesses rather than consumers, the buyer-side version of this — what to verify on a supplier, a certificate of analysis and a label before November — is set out separately in the buyer-side compliance checklist.
Change log
- 2026-08-19 — date-gate de-temporalization. Replaced live legislative and FDA-publication status wording with the enacted 2026-11-12 effective date, the dated 2026-08-08 Senate action, and the agency record reviewed through 2026-08-17; no later outcome is asserted.
- 2026-08-17 — unsupported interpretations removed. The page now treats layered packaging and broader rescheduling as unresolved without inventing a packaging reading or asserting an expired docket status.
- 2026-08-16 — first published. Established as the single maintained page for the federal change, replacing three earlier articles on the same subject. Two corrections were carried over in the process: earlier coverage on this site attributed the total-THC redefinition to a farm bill rather than to §781 of P.L. 119-37, and stated the 95% market figure flatly rather than presenting it as the industry estimate it is. Sources checked: congress.gov/crs-product/IF13136 and the April 2026 Federal Register order.
About this article
This article is general information about the law, published for educational purposes. It is not a substitute for the advice of an attorney. Laws change and vary by state — consult an attorney licensed in your jurisdiction about your specific situation. Jurisdiction covered: United States federal law, with state law where noted. Last verified: 2026-08-17.
What we checked for this page: the Congressional Research Service overview of the federal hemp redefinition (IF13136); the Federal Register rescheduling order published 2026-04-28; the Congressional Research Service legal sidebar on rescheduling (LSB11424); congressional records for H.R. 5371 and H.R. 6500; the Texas Register notice at 51 TexReg 4597; and the Texas Department of State Health Services consumable-hemp rules at 25 TAC ch. 300. Published by The FireBar Labs Team.
Frequently asked questions
What exactly happens on November 12, 2026?
The federal definition of hemp changes. From that date §781 of P.L. 119-37 measures hemp by total THC rather than delta-9 alone at the 0.3% dry-weight threshold, caps finished products at 0.4 mg of total THC per container, and excludes cannabinoids synthesized outside the plant (CRS IF13136). Products outside the rewritten definition are no longer federally lawful hemp.
Did the deadline move to December 11?
Section 781 of H.R. 5371, enacted as P.L. 119-37 on 2025-11-12, sets 2026-11-12 as the effective date for the hemp provisions. On 2026-08-08, the Senate passed H.R. 6500 containing proposed one-month partial-delay language; that language was not enacted as part of P.L. 119-37. The 90–6 roll call was passage of H.R. 6500, not a separate vote on hemp, and the proposed shift did not cover the synthetic-cannabinoid exclusion.
What does "0.4 mg per container" mean in practice?
Legally it is a ceiling on total THC in the innermost packaging that touches the product at retail, under §781 of P.L. 119-37. The sources reviewed through 2026-08-17 contained no FDA definition of "container," although the statutory deadline fell at roughly 2026-02-10 (CRS IF13136). This article therefore does not choose between whole-package and piece-by-piece measurements or assert later agency activity.
Does this make CBD illegal?
The change is written around tetrahydrocannabinols and the way they are measured, not around CBD as such (CRS IF13136). Whether any particular product clears a 0.4 mg total THC per-container figure is a question about that product's own certificate of analysis rather than about its marketing category — which is one reason a batch-specific certificate from an accredited laboratory is the document that answers it rather than a label. Certificates for our consumable products are published on our lab results page.
Is this the same as marijuana being rescheduled?
No — different statute, different agency, different track. The April 2026 order moved two narrow categories to Schedule III and left marijuana as a whole where it was (Federal Register, 2026-04-28), and broader rescheduling is still before an administrative law judge (CRS LSB11424).
Does a smell-proof bag change any of this?
No, and it is worth saying plainly. A bag is storage. It has no effect on the legal status of anything placed inside it, it does not alter what a product contains or how it is measured under §781 of P.L. 119-37, and it is not a defense to anything. What a well-made bag does is keep what you lawfully own contained, organized and private, in the ordinary way any decent piece of luggage does.
Explore FireBar Labs
Questions about any of this? Email support@firebarlabs.com — we respond within 24 hours.
Share:
Continue Reading
What a Buyer Must Verify in 2026: COAs, Packaging, Age Checks and the November Cliff
You Bought It Legally. Then Texas Rescheduled It.